;PMID: 10936679
;source_file_1357.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:42..172] = [t:42..172]
;2)section:[e:176..226] = [t:176..226]
;3)section:[e:230..373] = [t:230..373]
;4)sentence:[e:377..623] = [t:377..623]
;5)sentence:[e:624..751] = [t:624..751]
;6)sentence:[e:752..859] = [t:752..859]
;7)sentence:[e:860..993] = [t:860..993]
;8)sentence:[e:994..1205] = [t:994..1205]
;9)sentence:[e:1206..1367] = [t:1206..1367]
;10)section:[e:1371..1416] = [t:1371..1416]

;section 0 Span:0..37
;Cancer Lett  2000 Sep 1;157(2):185-91
(SEC
  (FRAG (NN:[0..6] Cancer) (NNP:[7..11] Lett) (CD:[13..17] 2000)
        (NNP:[18..21] Sep) (CD:[22..28] 1;157-LRB-) (CD:[28..29] 2)
        (-RRB-:[29..30] -RRB-) (CD:[30..34] :185) (HYPH:[34..35] -)
        (CD:[35..37] 91)))

;sentence 1 Span:42..172
;Beta-catenin and adenomatous polyposis coli (APC) mutations in adenomas from 
;hereditary non-polyposis colorectal cancer patients.
;[42..54]:gene-rna:"Beta-catenin"
;[59..85]:gene-rna:"adenomatous polyposis coli"
;[87..90]:gene-rna:"APC"
;[105..113]:malignancy:"adenomas"
;[120..162]:malignancy:"hereditary non-polyposis colorectal cancer"
(SENT
  (NP
    (NP
      (NP (NN:[42..54] Beta-catenin)
        (NML-1 (-NONE-:[54..54] *P*)))
      (CC:[55..58] and)
      (NP
        (NML
          (NML (JJ:[59..70] adenomatous) (NN:[71..80] polyposis)
               (NN:[81..85] coli))
          (NML (-LRB-:[86..87] -LRB-) (NN:[87..90] APC) (-RRB-:[90..91] -RRB-)))
        (NML-1 (NNS:[92..101] mutations))))
    (PP (IN:[102..104] in)
      (NP
        (NP (NNS:[105..113] adenomas))
        (PP (IN:[114..118] from)
          (NP
             (JJ:[120..130] hereditary)
            (NML (AFX:[131..134] non) (HYPH:[134..135] -)
                 (NN:[135..144] polyposis))
            (JJ:[145..155] colorectal) (NN:[156..162] cancer)
            (NNS:[163..171] patients)))))
    (.:[171..172] .)))

;section 2 Span:176..226
;Akiyama Y, Nagasaki H, Yagi KO, Nomizu T, Yuasa Y.
(SEC
  (FRAG (NNP:[176..183] Akiyama) (NNP:[184..185] Y) (,:[185..186] ,)
        (NNP:[187..195] Nagasaki) (NNP:[196..197] H) (,:[197..198] ,)
        (NNP:[199..203] Yagi) (NNP:[204..206] KO) (VBD:[206..207] ,)
        (NNP:[208..214] Nomizu) (NNP:[215..216] T) (,:[216..217] ,)
        (NNP:[218..223] Yuasa) (NNP:[224..226] Y.)))

;section 3 Span:230..373
;Department of Hygiene and Oncology, Tokyo Medical and Dental University
;School  of Medicine, 1-5-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan.
(SEC
  (FRAG (NNP:[230..240] Department) (IN:[241..243] of) (NNP:[244..251] Hygiene)
        (CC:[252..255] and) (NNP:[256..264] Oncology) (,:[264..265] ,)
        (NNP:[266..271] Tokyo) (NNP:[272..279] Medical) (CC:[280..283] and)
        (NNP:[284..290] Dental) (NNP:[291..301] University)
        (NNP:[302..308] School) (IN:[310..312] of) (NNP:[313..321] Medicine)
        (,:[321..322] ,) (CD:[323..324] 1) (HYPH:[324..325] -) (CD:[325..326] 5)
        (HYPH:[326..327] -) (CD:[327..329] 45) (NNP:[330..337] Yushima)
        (,:[337..338] ,) (NNP:[339..345] Bunkyo) (HYPH:[345..346] -)
        (JJ:[346..348] ku) (,:[348..349] ,) (CD:[350..353] 113)
        (HYPH:[353..354] -) (CD:[354..358] 8519) (,:[358..359] ,)
        (NNP:[360..365] Tokyo) (,:[365..366] ,) (NNP:[367..372] Japan)
        (.:[372..373] .)))

;sentence 4 Span:377..623
;To clarify the roles of the adenomatous polyposis coli (APC) and beta-catenin
; genes in hereditary nonpolyposis colorectal cancer (HNPCC) tumorigenesis, we
; searched for their mutations in 14 HNPCC adenomas with microsatellite 
;instability (MSI).
;[405..431]:gene-rna:"adenomatous polyposis coli"
;[433..436]:gene-rna:"APC"
;[442..454]:gene-rna:"beta-catenin"
;[465..506]:malignancy:"hereditary nonpolyposis colorectal cancer"
;[508..513]:malignancy:"HNPCC"
;[569..616]:malignancy:"HNPCC adenomas with microsatellite  instability"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[377..377] *))
      (VP (TO:[377..379] To)
        (VP (VB:[380..387] clarify)
          (NP
            (NP (DT:[388..391] the) (NNS:[392..397] roles))
            (PP (IN:[398..400] of)
              (PP (DT:[401..404] the)
                (NML
                  (NML
                    (NML
                      (NML (JJ:[405..416] adenomatous) (NN:[417..426] polyposis)
                           (NN:[427..431] coli))
                      (NML (-LRB-:[432..433] -LRB-) (NN:[433..436] APC)
                           (-RRB-:[436..437] -RRB-)))
                    (NML-1 (-NONE-:[437..437] *P*)))
                  (CC:[438..441] and)
                  (NML (NN:[442..454] beta-catenin)
                    (NML-1 (NNS:[456..461] genes)))))))
          (PP (IN:[462..464] in)
            (NP
              (NML
                (NML (JJ:[465..475] hereditary) (JJ:[476..488] nonpolyposis)
                     (JJ:[489..499] colorectal) (NN:[500..506] cancer))
                (NML (-LRB-:[507..508] -LRB-) (NN:[508..513] HNPCC)
                     (-RRB-:[513..514] -RRB-)))
              (NN:[515..528] tumorigenesis))))))
    (,:[528..529] ,)
    (NP-SBJ (PRP:[530..532] we))
    (VP (VBD:[534..542] searched)
      (PP (IN:[543..546] for)
        (NP (PRP$:[547..552] their) (NNS:[553..562] mutations)))
      (PP (IN:[563..565] in)
        (NP
          (NP (CD:[566..568] 14) (NN:[569..574] HNPCC) (NNS:[575..583] adenomas))
          (PP (IN:[584..588] with)
            (NP
              (NP (NN:[589..603] microsatellite) (NN:[605..616] instability))
              (NP (-LRB-:[617..618] -LRB-) (NN:[618..621] MSI)
                  (-RRB-:[621..622] -RRB-)))))))
    (.:[622..623] .)))

;sentence 5 Span:624..751
;Seven (50%) adenomas exhibited somatic APC mutations, five of  which were
;frameshift mutations and the other two nonsense ones.
;[636..644]:malignancy:"adenomas"
;[663..666]:gene-rna:"APC"
;[698..718]:variation-type:"frameshift mutations"
;[737..745]:variation-type:"nonsense"
(SENT
  (S
    (NP-SBJ (CD:[624..629] Seven)
      (PRN (-LRB-:[630..631] -LRB-)
        (NP (CD:[631..633] 50) (NN:[633..634] %))
        (-RRB-:[634..635] -RRB-))
      (NNS:[636..644] adenomas))
    (VP (VBD:[645..654] exhibited)
      (NP
        (NP (JJ:[655..662] somatic) (NN:[663..666] APC)
            (NNS:[667..676] mutations))
        (,:[676..677] ,)
        (SBAR
          (SBAR
            (WHNP-1
              (NP (CD:[678..682] five))
              (WHPP (IN:[683..685] of)
                (WHNP (WDT:[687..692] which))))
            (S
              (NP-SBJ-1 (-NONE-:[692..692] *T*))
              (VP (VBD:[693..697] were)
                (NP-PRD=3 (NN:[698..708] frameshift) (NNS:[709..718] mutations)))))
          (CC:[719..722] and)
          (SBAR
            (WHNP
              (NP-SBJ=2 (DT:[723..726] the) (JJ:[727..732] other)
                        (CD:[733..736] two)))
            (S
              (NP-PRD=3 (JJ:[737..745] nonsense) (NNS:[746..750] ones)))))))
    (.:[750..751] .)))

;sentence 6 Span:752..859
;However, the  APC mutational spectrum of these adenomas was similar to that
;of sporadic  colorectal tumors.
;[766..769]:gene-rna:"APC"
;[799..807]:malignancy:"adenomas"
;[831..858]:malignancy:"sporadic  colorectal tumors"
(SENT
  (S
    (ADVP (RB:[752..759] However))
    (,:[759..760] ,)
    (NP-SBJ
      (NP (DT:[761..764] the) (NN:[766..769] APC) (JJ:[770..780] mutational)
          (NN:[781..789] spectrum))
      (PP (IN:[790..792] of)
        (NP (DT:[793..798] these) (NNS:[799..807] adenomas))))
    (VP (VBD:[808..811] was)
      (ADJP-PRD (JJ:[812..819] similar)
        (PP (TO:[820..822] to)
          (NP
            (NP (DT:[823..827] that))
            (PP (IN:[828..830] of)
              (NP (JJ:[831..839] sporadic) (JJ:[841..851] colorectal)
                  (NNS:[852..858] tumors)))))))
    (.:[858..859] .)))

;sentence 7 Span:860..993
;Two adenomas (14.3%) with undetectable APC alterations showed  missense
;mutations at codon 45 (TCT to TTT or to CCT) in beta-catenin.
;[864..872]:malignancy:"adenomas"
;[899..902]:gene-rna:"APC"
;[923..941]:variation-type:"missense mutations"
;[945..953]:variation-location:"codon 45"
;[955..958]:variation-state-original:"TCT"
;[962..965]:variation-state-altered:"TTT"
;[972..975]:variation-state-altered:"CCT"
;[980..992]:gene-rna:"beta-catenin"
(SENT
  (S
    (NP-SBJ
      (NP (CD:[860..863] Two) (NNS:[864..872] adenomas))
      (PRN (-LRB-:[873..874] -LRB-)
        (NP (CD:[874..878] 14.3) (NN:[878..879] %))
        (-RRB-:[879..880] -RRB-))
      (PP (IN:[881..885] with)
        (NP (JJ:[886..898] undetectable) (NN:[899..902] APC)
            (NNS:[903..914] alterations))))
    (VP (VBD:[915..921] showed)
      (NP (JJ:[923..931] missense) (NNS:[932..941] mutations))
      (PP-LOC (IN:[942..944] at)
        (NP
           (NN:[945..950] codon) (CD:[951..953] 45)
          (PRN (-LRB-:[954..955] -LRB-)
            (NP
              (NP (NN:[955..958] TCT))
              (PP
                (PP (TO:[959..961] to)
                  (NP (NN:[962..965] TTT)))
                (CC:[966..968] or)
                (PP (TO:[969..971] to)
                  (NP (NN:[972..975] CCT)))))
            (-RRB-:[975..976] -RRB-))))
      (PP (IN:[977..979] in)
        (NP (NN:[980..992] beta-catenin))))
    (.:[992..993] .)))

;sentence 8 Span:994..1205
;The MSI  frequency in adenomas with beta-catenin mutations was significantly
;higher than  that with APCones (P<0.001), indicating that mutations of
;beta-catenin rather  than APC are strongly associated with MSI.
;[1016..1024]:malignancy:"adenomas"
;[1030..1042]:gene-rna:"beta-catenin"
;[1094..1097]:gene-rna:"APC"
;[1142..1154]:gene-rna:"beta-catenin"
;[1168..1171]:gene-rna:"APC"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[994..997] The) (NN:[998..1001] MSI) (NN:[1003..1012] frequency))
      (PP-LOC (IN:[1013..1015] in)
        (NP
          (NP (NNS:[1016..1024] adenomas))
          (PP (IN:[1025..1029] with)
            (NP (NN:[1030..1042] beta-catenin) (NNS:[1043..1052] mutations))))))
    (VP (VBD:[1053..1056] was)
      (ADJP-PRD
        (ADJP (RB:[1057..1070] significantly) (JJR:[1071..1077] higher))
        (PP (IN:[1078..1082] than)
          (NP
            (NP (DT:[1084..1088] that))
            (PP (IN:[1089..1093] with)
              (NP (NN:[1094..1097] APC) (NNS:[1097..1101] ones))))))
      (PRN (-LRB-:[1102..1103] -LRB-)
        (S
          (NP-SBJ (NN:[1103..1104] P))
          (VP (SYM:[1104..1105] <)
            (NP (CD:[1105..1110] 0.001))))
        (-RRB-:[1110..1111] -RRB-))
      (,:[1111..1112] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1112..1112] *))
        (VP (VBG:[1113..1123] indicating)
          (SBAR (IN:[1124..1128] that)
            (S
              (NP-SBJ
                (NP (NNS:[1129..1138] mutations))
                (PP (IN:[1139..1141] of)
                  (NP
                    (NP (NN:[1142..1154] beta-catenin))
                    (PP (IN:[1155..1161] rather)
                      (PP (IN:[1163..1167] than)
                        (NP (NN:[1168..1171] APC)))))))
              (VP (VBP:[1172..1175] are)
                (ADVP (RB:[1176..1184] strongly))
                (VP (VBN:[1185..1195] associated)
                  (PP-CLR (IN:[1196..1200] with)
                    (NP (NN:[1201..1204] MSI))))))))))
    (.:[1204..1205] .)))

;sentence 9 Span:1206..1367
;These data suggest that adenomas with  beta-catenin activating mutations and
;some with APC inactivating mutations may  be precursors of HNPCC colorectal
;cancers.
;[1230..1238]:malignancy:"adenomas"
;[1245..1257]:gene-rna:"beta-catenin"
;[1293..1296]:gene-rna:"APC"
;[1342..1366]:malignancy:"HNPCC colorectal cancers"
(SENT
  (S
    (NP-SBJ (DT:[1206..1211] These) (NNS:[1212..1216] data))
    (VP (VBP:[1217..1224] suggest)
      (SBAR (IN:[1225..1229] that)
        (S
          (NP-SBJ
            (NP
              (NP (NNS:[1230..1238] adenomas))
              (PP (IN:[1239..1243] with)
                (NP (NN:[1245..1257] beta-catenin) (VBG:[1258..1268] activating)
                    (NNS:[1269..1278] mutations))))
            (CC:[1279..1282] and)
            (NP
              (NP (DT:[1283..1287] some))
              (PP (IN:[1288..1292] with)
                (NP (NN:[1293..1296] APC) (VBG:[1297..1309] inactivating)
                    (NNS:[1310..1319] mutations)))))
          (VP (MD:[1320..1323] may)
            (VP (VB:[1325..1327] be)
              (NP-PRD
                (NP (NNS:[1328..1338] precursors))
                (PP (IN:[1339..1341] of)
                  (NP (NN:[1342..1347] HNPCC) (JJ:[1348..1358] colorectal)
                      (NNS:[1359..1366] cancers)))))))))
    (.:[1366..1367] .)))

;section 10 Span:1371..1416
;PMID: 10936679 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1371..1375] PMID) (::[1375..1376] :) (CD:[1377..1385] 10936679)
        (IN:[1386..1387] -LSB-) (NNP:[1387..1393] PubMed) (HYPH:[1394..1395] -)
        (JJ:[1396..1403] indexed) (IN:[1404..1407] for)
        (NNP:[1408..1416] MEDLINE-RSB-)))
